InNexus Biotechnology Inc. (IXS.V)
-TSXV 0.01 0.00(0.00%) Nov 3, 1:27PM EDT
| Prev Close: | 0.01 |
|---|
| Open: | N/A |
|---|
| Bid: | 0.01 |
|---|
| Ask: | 0.02 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.01 - 0.01 |
|---|
| 52wk Range: | 0.01 - 0.04 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 0 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- No Headlines available for IXS.V at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
InNexus Biotechnology, Inc., a development stage company, engages in the commercialization of monoclonal antibodies based on its Dynamic Cross Linking (DXL) technology.
View More